Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-09-25The Effect of Cilostazol on the Clinical Outcome of Patients with Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-08-29Identification of the Missing Genetic Causes of Parkinsonian Syndromes: a Combined Approach by Genome and RNA Sequencing
-
CLINICAL_TRIALS study record update · 2024-08-216-weeks, Open-label, Single-Site Study to Evaluate Safety, Tolerability and Efficacy of the Home-based Peroneal Electrical Transcutaneous NeuroModulation (Peroneal eTNM®) Treatment Via Nerve Stimulator URIS ITM in Treatment of Symptoms Related to Movement Disorders in Subjects With Parkinson's Disease (PD) and Essential Tremor (ET)
-
CLINICAL_TRIALS study record update · 2024-08-15A Randomized, Open-Label, Single Oral Dose, Three-Way Cross-Over Trial to Evaluate the Relative Bioavailability of CVN424 Suspension &Tablet Formulations Including an Assessment of the Effect of Food on the Tablet Formulation in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2024-08-05A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects The Purpose of the Study is to Evaluate the Safety, Tolerability After Administration of Single Dose or Multiple Doses, and the Pharmacokinetics (PK) of Single and Multiple Doses of JX2105 in Healthy Study Participants.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-31A Multi-center, Noninterventional Study Evaluating Variability, Reliability, and Compliance for the Parkinson's Disease Diary
-
CLINICAL_TRIALS study record update · 2024-07-26A Randomized, Double-blind, Placebo-controlled Trial of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-07-26Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of Allogenic Embryonic Stem Cell-derived A9 Dopamine Progenitor Cell (A9-DPC) in SB-PD-001 Study
-
CLINICAL_TRIALS study record update · 2024-07-24Genetic Epidemiology of Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-07-22Cognitive Rehabilitation for Veterans With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-07-09Effects of Dual-task Training With Exergame and Treadmill on Executive Function, Dual-task Performance and Cortical Activation in Individuals With Parkinson's Disease and Stroke
-
CLINICAL_TRIALS study record update · 2024-07-08NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
-
CLINICAL_TRIALS study record update · 2024-07-08A Multicenter, Participant-Blind, Investigator-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of UCB7853 in Healthy Male Study Participants and Multiple Ascending Doses in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-06-21Highly Challenging Balance Program to Reduce Fall Rate in PD
-
CLINICAL_TRIALS study record update · 2024-05-20Barriers and Motivators Associated With Access to Care and Participation in Research Studies for Parkinson's Disease Among Asian Americans
-
CLINICAL_TRIALS study record update · 2024-05-16A Phase 2, Pilot Open Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-05-14The Parkinson's Genetic Research Study (PaGeR)
-
CLINICAL_TRIALS study record update · 2024-05-13Sensory Gating Measured With Microelectrode Recording During Deep Brain Stimulation Surgery
-
CLINICAL_TRIALS study record update · 2024-05-10Can High-intensity Exercise be Used to Treat Fatigue in Parkinson´s Disease?
-
CLINICAL_TRIALS study record update · 2024-05-09Italian Translation and Validation of the Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire.
-
CLINICAL_TRIALS study record update · 2024-05-09Home-based High-intensity Interval Training for People With Parkinson's: The HIIT-Home4Parkinson's Randomised Controlled Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-05-01A Phase I/IIa, Single Dose, Single-centre, Randomized, Crossover, Double-blind, Placebo-controlled Study Evaluating Safety, Tolerability and Levodopa Plasma Concentration Following Administration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD Patients
-
CLINICAL_TRIALS study record update · 2024-04-30Effect of Task-Oriented Virtual Reality Access With Crowd Simulation on Freezing Phenomenon, Balance, Functional Mobility, Participation and Quality of Life in Parkinson's Patients
-
CLINICAL_TRIALS study record update · 2024-04-29A Multicenter, Open-Label, Randomized, Dose-Finding Study Testing the Safety, Tolerability, and Pharmacokinetics (PK) of ND0612, a Liquid Formulation of Levodopa/Carbidopa (LD/CD) Delivered as a Continuous Subcutaneous Infusion (SC) in Parkinson's Disease (PD) Patients Treated With LD
-
CLINICAL_TRIALS study record update · 2024-04-25Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects